Request to Join
has invited you to join this group
Jennifer Joe, MD, is a Harvard-affiliated Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) nephrology graduate turned physician entrepreneur CEO and Founder of Medstro.com, a new and innovative social network for physicians, whose clients include The NEJM Group and Google, among others. Dr. Joe still regularly works the VA emergency room and urgent care clinics. As Editor-in-Chief of MedTech Boston and being based in Kendall Square, arguably the physical collision point of technology and academic medicine, Dr. Joe interacts and supports new medicalinnnovation and technology and has insights on best uses. In this role, she has been a mentor at the Massachusetts General Hospital-Samsung-MIT Hacking Medicine and the Tufts Medstart hackathons in the last year. She was a judge of this year’s athenahealth More Disruption Please hackathon and the Office of the National Coordinator Market R&D Pilot Challenge. Because of her insights, Dr. Joe has spoken at South by Southwest, South by Southwest V2V, Health 2.0, the Mass Medical Society EHR Conference, IN3 Medical Device 360, and the Mass TLC Healthcare Conference. Dr. Joe is also a member of the Massachusetts Medical Society Committee on IT and Committee on Communications and is the Massachusetts American College of Physicians Information Officer.
John Kwon is currently a research associate at the Broad Institute. He graduated from the University of Notre Dame with a degree in Biological Sciences. John has a strong passion for research in cellular biology and oncology. At Notre Dame, he has worked in a cellular biology lab under the mentorship of Dr. Kevin Vaughan. His senior thesis focused on understanding how mitotic proteins contribute to cell cycle regulation and modulation of chromatin structure. Outside of research, John has been involved in mentoring undergraduates and volunteering in the local community. He enjoys teaching and providing guidance for students, as well as learning from his own peers and mentors. His current interest to explore genomics has brought him to the Broad Institute. John is collaborating with an MD/PhD student to genetically engineer melanoma cells from normal primary melanocytes using CRISPR/Cas9 technology. This work will shed greater insight into how melanoma develops in patients. In the near future, John plans to pursue his studies in medicine with a strong emphasis on research.